Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Bayer Schering Will Build $129 Million Beijing R&D Center

publication date: Feb 12, 2009

Bayer Schering Pharma of Germany will invest $129 million to build a global R&D center located in Beijing. The investment will take place over five years. For Bayer Schering, China is the third largest market, and the company already has already located R&D centers in the US and Europe, its two markets that are larger than China. The Beijing center will be very mindful of the clinical profile and medical needs of Asian patients, though the center is not exclusively devoted to the Asian market. More details...

Stock Symbol: (Frankfurt: SCH)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here